Article
Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
Acta neurologica Scandinavica - 1 Aug 2022
Hayat Shoma, Asad Asaduzzaman, Hasan Imran, Jahan Israt, Papri Nowshin, Howlader Zakir Hossain, Islam Zhahirul
Abstract excerpt
OBJECTIVES: Nucleotide oligomerization domain (NOD) proteins are cytoplasmic receptors that play important roles in host innate immune responses to pathogens by recognizing self or non-self-molecules and have been implicated in many autoimmune diseases including Guillain-Barré syndrome (GBS). The current study investigated whether NOD polymorphisms (NOD1-Glu266Lys, rs2075820, and NOD2- [Arg702Trp, rs2066844 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
